126 related articles for article (PubMed ID: 12351613)
1. Epirubicin, Cisplatin, and protracted venous-infusion Fluorouracil in advanced esophagogastric cancer.
Leonard GD; Zhuang SH; Grem JL
J Clin Oncol; 2002 Oct; 20(19):4124-5; author reply 4125-6. PubMed ID: 12351613
[No Abstract] [Full Text] [Related]
2. A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.
Karapetis CS; Cheong KA; Yip D; Strickland AH; Steer C; Marx G; Yip S; Chrystal K; Harper PG
Asia Pac J Clin Oncol; 2010 Dec; 6(4):298-305. PubMed ID: 21114780
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Ross P; Nicolson M; Cunningham D; Valle J; Seymour M; Harper P; Price T; Anderson H; Iveson T; Hickish T; Lofts F; Norman A
J Clin Oncol; 2002 Apr; 20(8):1996-2004. PubMed ID: 11956258
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
6. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Webb A; Cunningham D; Scarffe JH; Harper P; Norman A; Joffe JK; Hughes M; Mansi J; Findlay M; Hill A; Oates J; Nicolson M; Hickish T; O'Brien M; Iveson T; Watson M; Underhill C; Wardley A; Meehan M
J Clin Oncol; 1997 Jan; 15(1):261-7. PubMed ID: 8996151
[TBL] [Abstract][Full Text] [Related]
7. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
Chua YJ; Cunningham D
Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
[No Abstract] [Full Text] [Related]
8. Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?
Ilson DH
J Clin Oncol; 2002 Apr; 20(8):1962-4. PubMed ID: 11956251
[No Abstract] [Full Text] [Related]
9. Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.
Khanna A; Reece-Smith AM; Cunnell M; Madhusudan S; Thomas A; Bowrey DJ; Parsons SL
Dis Esophagus; 2014 Apr; 27(3):242-7. PubMed ID: 23651074
[TBL] [Abstract][Full Text] [Related]
10. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. The MRC Gastric Cancer Working Party and the British Stomach Cancer Group.
Allum WH
Br J Surg; 1995 Apr; 82(4):565. PubMed ID: 7542143
[No Abstract] [Full Text] [Related]
12. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.
Cho EK; Lee WK; Lim DY; Bang SM; Park DK; Park YH; Kwon OS; Choi DJ; Shin DB; Lee JH; Lee TH
J Korean Med Sci; 2002 Jun; 17(3):348-52. PubMed ID: 12068138
[TBL] [Abstract][Full Text] [Related]
13. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).
Findlay M; Cunningham D; Norman A; Mansi J; Nicolson M; Hickish T; Nicolson V; Nash A; Sacks N; Ford H
Ann Oncol; 1994 Sep; 5(7):609-16. PubMed ID: 7993836
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma.
Corporaal S; Smit WM; Russel MG; van der Palen J; Boot H; Legdeur MC
Neth J Med; 2006 May; 64(5):141-6. PubMed ID: 16702612
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma.
Highley MS; Parnis FX; Trotter GA; Houston SJ; Penson RT; Harper PG; Mason RC
Br J Surg; 1994 Dec; 81(12):1763-5. PubMed ID: 7530150
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
Bamias A; Cunningham D; Nicolson V; Norman A; Hill M; Nicolson M; O'Brien M; Webb A; Hill A
Br J Cancer; 1995 Mar; 71(3):583-6. PubMed ID: 7880742
[TBL] [Abstract][Full Text] [Related]
17. Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer.
Sirohi B; Barreto SG; Singh A; Batra S; Mittra A; Rastogia S; Ramadwar M; Shetty N; Goel M; Shrikhande SV
J Cancer Res Ther; 2014; 10(4):866-70. PubMed ID: 25579520
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction.
Forshaw MJ; Gossage JA; Chrystal K; Cheong K; Atkinson S; Botha A; Harper PG; Mason RC
Eur J Surg Oncol; 2006 Dec; 32(10):1114-8. PubMed ID: 16621430
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine and oxaliplatin for advanced esophagogastric cancer.
Cunningham D; Okines AF; Ashley S
N Engl J Med; 2010 Mar; 362(9):858-9. PubMed ID: 20200397
[No Abstract] [Full Text] [Related]
20. Intermittent continuous infusion of 5-fluorouracil in combination with epirubicin and cisplatin in advanced gastric cancer: the importance of dose intensity.
Poorter RL; Bakker PJ; Fockens P; Taat CW; Bartelsman JF; Veenhof CH
J Infus Chemother; 1996; 6(2):87-91. PubMed ID: 8809656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
